UCP2 promotes NSCLC proliferation and glycolysis via the mTOR/HIF‐1α signaling
Abstract Background Metabolic disturbance is a hallmark of cancers. Targeting key metabolic pathways and metabolism‐related molecular could be a potential therapeutic approach. Uncoupling protein 2 (UCP2) plays a pivotal part in the malignancy of cancer and its capacity to develop resistance to phar...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wiley
2024-02-01
|
| Reeks: | Cancer Medicine |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1002/cam4.6938 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|